Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018;中国急性缺血性脑卒中诊治指南2018

Chinese Journal of Neurology

Volumn 51, Issue 9, 2018, Pages 666-682

  Chinese Society of Neurology, ^a   Chinese Stroke Society, ^a  

^a NONE

Author keywords

Brain ischemia; Diagnosis; Guidebooks; Stroke; Treatment

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BRAIN ISCHEMIA; CHINESE; EMERGENCY CARE; ENDOVASCULAR SURGERY; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL SOCIETY; MULTIMODAL IMAGING; NEUROIMAGING; NEUROLOGY; PRACTICE GUIDELINE;

EID: 85063692502     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1006-7876.2018.09.004     Document Type: Article

References (109)

1. Wang W, Jiang B, Sun H, et al. Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480687 Adults[J]. Circulation, 2017, 135(8): 759-771. DOI:10.1161/CIRCULATIONAHA.116.025250.
2. Wang D, Liu J, Liu M, et al. Patterns of Stroke Between University Hospitals and Nonuniversity Hospitals in Mainland China: Prospective Multicenter Hospital-Based Registry Study[J]. World Neurosurg, 2017, 98: 258-265. DOI:10.1016/j.wneu.2016.11.006.
3. Huang Y, Wang JG, Wei JW, et al. Age and gender variations in the management of ischaemic stroke in China[J]. Int J Stroke, 2010, 5(5): 351-359. DOI:10.1111/j.1747-4949.2010.00460.x.
4. 郝子龙, 刘鸣, 李伟, 等. 成都卒中登记方法及3123例患者基本特征和功能结局[J]. 中华神经科杂志, 2011, 44(12): 826-831. DOI:10.3760/cma.j.issn.1006-7876.2011.12.006. Hao ZL, Liu M, Li W, et al. Basic characteristics and functional outcomes of consecutive 3123 patients in Chengdu stroke registry[J]. Chin J Neurol, 2011, 44(12): 826-831. DOI:10.3760/cma.j.issn.1006-7876.2011.12.006.
5. Wang Z, Li J, Wang C, et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry[J]. PLoS One, 2013, 8(2): e56459. DOI:10.1371/journal.pone.0056459.
6. 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4): 246-257. DOI:10.3760/cma.j.issn.1006-7876.2015.04.002 Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2014[J]. Chin J Neurol, 2015|, 48(4): 246-257. DOI:10.3760/cma.j.issn.1006-7876.2015.04.002.
7. 中华医学会神经病学分会, 中华医学会神经病学分会神经血管介入协作组, 急性缺血性脑卒中介入诊疗指南撰写组. 中国急性缺血性脑卒中早期血管内介入诊疗指南[J]. 中华神经科杂志, 2015, 48(5): 356-361. DOI:10.3760/cma.j.issn.1006-7876.2015.05.002.Chinese Society of Neurology, Neurovascular Intervention Group of Chinese Society of Neurology, Writing Group of Guidelines for Interventional Therapy in Acute Ischemic Stroke. Guidelines for early endovascular diagnosis and treatment of acute ischemic stroke in China[J]. Chin J Neurol, 2015, 48(5): 356-361. DOI:10.3760/cma.j.issn.1006-7876.2015.05.002.
8. Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients with Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(10): 3020-3035. DOI:10.1161/STR.0000000000000074.
9. Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[j]. Stroke, 2018, 49(3): e46-110. DOI:10.1161/STR.0000000000000158.
10. World Stroke Organization. Clinical practice guideline development across the stroke continuum of care[OL]. [2015-1-27]. http://www.world-stroke.org/images/guidelines.pdf.
11. Ekundayo OJ, Saver JL, Fonarow GC, et al. Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With The Guidelines-Stroke. Circ Cardiovasc Qual Outcomes, 2013, 6(3): 262-269. DOI:10.1161/CIRCOUTCOMES.113.000089.
12. Singletary EM, Charlton NP, Epstein JL, et al. Part 15: First Aid: 2015 American Heart Association and American Red Cross Guidelines Update for First Aid[J]. Circulation, 2015, 132(18 Suppl 2): S574-589. DOI:10.1161/CIR.0000000000000269.
13. Jauch EC, Saver JL, Adams HP Jr, on behalf of the American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2013, 44(3): 870-947. DOI:10.1161/STR.0b013e318284056a.
14. Fong WC, Ismail M, Lo JW, et al. Telephone and Teleradiology-Guided Thrombolysis Can Achieve Similar Outcome as Thrombolysis by Neurologist On-site[J]. J Stroke Cerebrovasc Dis, 2015, 24(6): 1223-1228. DOI:10.1016/j.jstrokecerebrovasdis.2015.01.022.
15. Barlinn J, Gerber J, Barlinn K, et al. Acute endovascular treatment delivery to ischemic stroke patients transferred within a telestroke network: a retrospective observational study[J]. Int J Stroke, 2017, 12(5): 502-509. DOI:10.1177/1747493016681018.
16. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke[J/CD]. Cochrane Database Syst Rev, 2013, 9: CD000197. DOI:10.1002/14651858.CD000197.pub3.
17. Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS tPA Stroke Study Group[J]. Stroke, 1994, 25(11): 2220-2226
18. Josephson SA, Hills NK, Johnston SC. NIH Stroke Scale reliability in ratings from a large sample of clinicians[J]. Cerebrovasc Dis, 2006, 22(5-6): 389-395. DOI:10.1159/000094857.
19. Lyden P, Raman R, Liu L, et al. National Institutes of Health Stroke Scale certification is reliable across multiple venues[J]. Stroke, 2009, 40(7): 2507-2511. DOI:10.1161/STROKEAHA.108.532069.
20. 脑卒中患者临床神经功能缺损程度评分标准(1995)[J]. 中华神经科杂志, 1996, 29(6): 381-383. Scoring criteria for clinical neurological deficit in stroke patients (1995)[J]. Chin J Neurol, 1996|, 29(6): 381-383.
21. Lindenstrom E, Boysen G, Christiansen LW, et al. Reliability of Scandinavian Stroke Scale[J]. Cerebrovasc Dis, 1991, 1(2): 103-107.
22. Hacke W, Albers G, Al-Rawi Y, et al; for the DIAS Study Group. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase Ⅱ MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase[J]. Stroke, 2005, 36(1): 66-73. DOI:10.1161/01.STR.0000149938.08731.2c.
23. Albers GW, Thijs VN, Wechsler L, et al; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) study[J]. Ann Neurol, 2006, 60(5): 508-517. DOI:10.1002/ana.20976.
24. Hacke W, Furlan AJ, Al-Rawi Y, et al. Intravenous desmoteplase in patients with 216 acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study[J]. Lancet Neurol, 2009, 8(2): 141-150. DOI:10.1016/S1474-4422(08)70267-9.
25. 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑血管病影像运用指南[J]. 中华神经科杂志, 2016, 49(3): 164-181. DOI:10.3760/cma.j.issn.1006-7876.2016.03.002.Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for application of imaging in cerebral vascular diseases[J]. Chin J Neurol, 2016, 49(3): 164-181. DOI:10.3760/cma.j.issn.1006-7876.2016.03.002.
26. 杨璐萌, 程忻, 凌倚峰, 等. 急性缺血性卒中静脉溶栓前是否需等待血小板计数和凝血功能指标[J]. 中华神经科杂志, 2014, 47(7): 464-468. DOI:10.3760/cma.j.issn.1006-7876.2014.07.006. Yang LM, Cheng X, Ling YF, et al. Is it necessary to wait for platelet count and coagulation results before intravenous thrombolysis in acute ischemic stroke?[J]. Chin J Neurol, 2014, 47(7): 464-468.DOI:10.3760/cma.j.issn.1006-7876.2014.07.006.
27. Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association[J]. Stroke, 2016, 47(2): 581-641. DOI:10.1161/STR.0000000000000086.
28. World Health Organization. ICD-11 for mortality and morbidity statistics (2018). 8B11. Cerebral Ischemic stroke.[2018-6-20]. https://icd.who.int/browse11/l-m/en#/.
29. Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists[J]. Stroke, 2009, 40(6): 2276-2293. DOI:10.1161/STROKEAHA.108.192218.
30. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for Use in a Multicenter Clinical Trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment[J]. Stroke, 1993, 24(1): 35-41.
31. Tikhonoff V, Zhang H, Richart T, et al. Blood pressure as a prognostic factor after acute stroke[J]. Lancet Neurol, 2009, 8(10): 938-948. DOI:10.1016/S1474-4422(09)70184-X.
32. 谭燕, 刘鸣, 王清芳, 等. 脑卒中急性期血压与预后的关系[J]. 中华神经科杂志, 2006, 39(1): 10-15. DOI:10.3760/j.issn: 1006-7876.2006.01.004. Tan Y, Liu M, Wang QF, et al. Blood pressure and prognosis in patients with acute stroke[J]. Chin J Neurol, 2006, 39(1): 10-15. DOI:10.3760/j.issn: 1006-7876.2006.01.004.
33. He J, Zhang Y, Xu T, et al. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial[J]. JAMA, 2014, 311(5): 479-489. DOI:10.1001/jama.2013.282543.
34. Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II Trial[J]. Stroke, 2008, 39(10): 2749-2755. DOI:10.1161/STROKEAHA.108.514307.
35. Bruno A, Kent TA, Coull BM, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial[J]. Stroke, 2008, 39(2): 384-389. DOI:10.1161/STROKEAHA.107.493544.
36. Scott JF, Robinson GM, French JM, et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST)[J]. Stroke, 1999, 30(4): 793-799.
37. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995, 333(24): 1581-1587.
38. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med, 2008, 359(13): 1317-1329. DOI:10.1056/NEJMoa0804656.
39. IST-3 collaborative group, Sandercock P, Wardlaw JM, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial[IST-3]): a randomised controlled trial[J]. Lancet, 2012, 379(9834): 2352-2363. DOI:10.1016/S0140-6736(12)60768-5.
40. Hacke W, Donnan G, Fieschi C, et al; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials[J]. Lancet, 2004, 363(9411): 768-774. DOI:10.1016/S0140-6736(04)15692-4.
41. Wardlaw JM, Murray V, Berge E, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis[J]. Lancet, 2012, 379(9834): 2364-2372. DOI:10.1016/S0140-6736(12)60738-7.
42. Lees KR, Emberson J, Blackwell L, et al. Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials[J]. Stroke, 2016, 47(9): 2373-2379. DOI:10.1161/STROKEAHA.116.013644.
43. Thomalla G, Simonsen CZ, Boutitie F, et al. MRI-Guide Thrombolysis for Stroke with Unknown Time of Onset[j]. N Engl J Med, 2018 May 16. Epub ahead of print. DOI:10.1056/NEJMoa1804355.
44. Foster-Goldman A, McCarthy D. Angioedema from recombinant TPA administration: case report and pathophysiology review[J]. Am J Ther, 2013, 20(6): 691-693. DOI:10.1097/MJT.0b013e3182799083.
45. Gorski EM, Schmidt MJ. Orolingual angioedema with alteplase administration for treatment of acute ischemic stroke[J]. J Emerg Med, 2013, 459(1): e25-26. DOI:10.1016/j.jemermed.2013.02.004.
46. 国家"九五"攻关课题协作组. 急性脑梗死(6h以内)静脉溶栓治疗[J]. 中风与神经疾病杂志, 2001, 18(5): 259-261.Cooperating Group for National "95" Project. Intravenous thrombolytic therapy in acute cerebral infarction (within 6 h)[J]. J Apoplexy Nerv Dis, 2001, 18(5): 259-261.
47. 国家"九五"攻关课题协作组. 急性脑梗死六小时以内的静脉溶栓治疗[J]. 中华神经科杂志, 2002, 35(4): 210-213.Cooperating Group for National "95" Project. Intravenous thrombolysis with urokinase for acute cerebral infarctions[J]. Chin J Neurol, 2002, 35(4): 210-213.
48. Goyal M, Menon BK, Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016, 387(10029): 1723-1731. DOI:10.1016/S0140-6736(16)00163-X.
49. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6-24 Hours after Stroke with a Mismatch between Deficit and Infarct[J]. N Engl J Med, 2018, 378(1): 11-21. DOI:10.1056/NEJMoa1706442.
50. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for Stroke at 6-16 Hours with Selection by Perfusion Imaging[j]. N Engl J Med, 2018, 378(8): 708-718. DOI:10.1056/NEJMoa1713973.
51. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT Ⅱ Study: A Randomized Controlled Trial. Prolyse in Acute Cerebral Thromboembolism[J]. JAMA, 1999, 282(21): 2003-2011.
52. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials[J]. Stroke, 2010, 41(5): 932-937. DOI:10.1161/STROKEAHA.109.574335.
53. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: a randomized placebo-controlled trial of early aspirin use in 20, 000 patients with acute ischaemic stroke[J]. Lancet, 1997, 349(9066): 1641-1649.
54. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke[J]. Lancet, 1997, 349(9065): 1569-1581.
55. Wang Y, Wang Y, Zhao X, et al; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med, 2013, 369(1): 11-19. DOI:10.1056/NEJMoa1215340.
56. Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA[J]. N Engl J Med, 2018 May 16. Epub ahead of print. DOI:10.1056/NEJMoa1800410.
57. Sandercock PA, Counsell C, Kamal AK. Anticoagulants for acute ischaemic stroke[J/CD]. Cochrane Database Syst Rev, 2008, (4): CD000024.
58. Whiteley WN, Adams HP Jr, Bath PM, et al. Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials[J]. Lancet Neurol, 2013, 12(6): 539-545. DOI:10.1016/S1474-4422(13)70079-6.
59. Sandercock PA, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke[J]. Cochrane Database Syst Rev, 2015, (3): CD000024.
60. Yi X, Lin J, Wang C, et al. Low-molecular-weight heparin is more effective than aspirin in preventing early neurologic deterioration and improving six-month outcome[J]. J Stroke Cerebrovasc Dis, 2014, 23(6): 1537-1544. DOI:10.1016/j.jstrokecerebrovasdis.2013.12.036.
61. LaMonte MP, Nash ML, Wang DZ, et al. Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study[J]. Stroke, 2004, 35(7): 1677-1682.
62. Barreto AD, Ford GA, Shen L, et al. Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)[J]. Stroke, 2017, 48(6): 1608-1616. DOI:10.1161/STROKEAHA.117.016720.
63. 全国降纤酶临床再评价研究协作组. 降纤酶治疗急性脑梗死的临床再评价: 多中心前瞻性随机双盲对照研究[J]. 中华神经科杂志, 2000, 33(5): 263-267.The Cooperative Group for Reassessment of Defibrase, China. Reassessment of defibrase in treatment of cerebral infarction[J]. Chin J Neurol, 2000, 33(5): 263-267.
64. 全国降纤酶临床再评价研究协作组. 降纤酶治疗急性脑梗死临床再评价(Ⅱ)[J]. 中华神经科杂志, 2005, 38(1): 11-16.The Cooperative Group for Reassessment of Defibrase, China. Reassessment of defibrase in treatment of cerebral infarction (Ⅱ)[J]. Chin J Neurol, 2005, 38(1): 11-16.
65. 陈清棠, 赵玉宾, 郑亚文, 等. 巴曲酶注射液(东菱迪芙, 即东菱精纯克栓酶)治疗急性脑梗死的临床试验[J]. 中风与神经疾病杂志, 2000, 17(1): 27-30. Chen QT, Zhao YB, Zheng YW, et al. Clinical trial of Batroxobin Injection (Donlim) in treating acute cerebral infarction[J]. J Apoplexy Nerv Dis, 2000, 17(1): 27-30.
66. 国家"十五"攻关课题协作组. 尿激酶和巴曲酶治疗早期急性脑梗死的疗效和安全性研究[J]. 中华老年心脑血管病杂志, 2006, 8(2): 104-107.The Cooperating Group for National "Tenth Five-year" Project. Efficacy and safety of urokinase and Batroxobin in the treatment of early acute cerebral infarction[J]. Chin J Geriatr Cardio-cerebrovasc Dis, 2006, 8(2): 104-107.
67. Chang TS, Jensen MB. Haemodilution for acute ischaemic stroke[J]. Cochrane Database Syst Rev, 2014, (8): CD000103.
68. Shuaib A, Butcher K, Mohammad A, et al. Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target[J]. Lancet Neurol, 2011, 10(10): 909-921. DOI:10.1016/S1474-4422(11)70195-8.
69. Bang OY, Goyal M, Liebeskind DS. Collateral Circulation in Ischemic Stroke: Assessment Tools and Therapeutic Strategies[J]. Stroke, 2015, 46(11): 3302-3309. DOI:10.1161/STROKEAHA.115.010508.
70. 徐皓亮, 冯亦璞. 丁基苯酞对局灶性脑缺血大鼠软脑膜微循环障碍的影响[J]. 药学学报, 1999, 34(3): 172-175. Xu HL, Feng YP. dl-3n-Butylphthalide improve leptomeningeal circulation in focal cerebral ischemia rat model [J]. Acta Pharmaceutica Sinica, 1999, 34(3): 172-175.
71. Lu XL, Luo D, Yao XL, et al. dl-3n-Butylphthalide promotes angiogenesis via the extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase/Akt-endothelial nitric oxide synthase signaling pathways[J]. J Cardiovasc Pharmacol, 2012, 59(4): 352-362. DOI:10.1097/FJC.0b013e3182443e74.
72. Xiong Z, Lu W, Zhu L, et al. Dl-3-n-Butylphthalide Treatment Enhances Hemodynamics and Ameliorates Memory Deficits in Rats with Chronic Cerebral Hypoperfusion[J]. Front Aging Neurosci, 2017, 9: 238. DOI:10.3389/fnagi.2017.00238.
73. 崔丽英, 刘秀琴, 朱以诚, 等. dl-3-正丁基苯酞治疗中度急性缺血性脑卒中的多中心, 随机, 双盲和安慰剂对照研究[J]. 中华神经科杂志, 2005, 38(4): 251-254. Cui LY, Liu XQ, Zhu YC, et al. Effects of dl-3-Butylphthalide on treatment of acute ischemic stroke with moderate symptoms: a multi-center, randomized, double-blind, placebo-control trial[J]. Chin J Neurol, 2005, 38(4): 251-254.
74. 崔丽英, 李舜伟, 吕传真, 等. 恩必普软胶囊治疗中度急性缺血性卒中的多中心开放临床研究[J]. 中国脑血管病杂志, 2005, 2(3): 112-115. Cui LY, Li SW, Lyu CZ, et al. The multicentric randomized study of dl-3-butylphthalide in the treatment of acute moderate ischemic stroke[J]. Chin J Cerebravasc Dis, 2005, 2(3): 112-115.
75. 崔丽英, 李舜伟, 张微微, 等. dl-3-正丁基苯酞软胶囊与阿司匹林治疗急性缺血性脑卒中的多中心, 随机, 双盲双模拟对照研究[J]. 中华神经科杂志, 2008, 41(11): 727-730. DOI:10.3321/j.issn: 1006-7876.2008.11.003. Cui LY, Li SW, Zhang WW, et al. Effects of dl-3-butylphthalide soft capsules on treatment of acute ischemic stroke: multi-center, randomized, double-blind, double-dummy and aspirin-control study[J]. Chin J Neurol, 2008, 41(11): 727-730. DOI:10.3321/j.issn: 1006-7876.2008.11.003.
76. Cui LY, Zhu YC, Gao S, et al. Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: a randomized, double-blind trial[J]. Chin Med J, 2013, 126(18): 3405-3410.
77. 李昌盛, 闵喆, 湛彦强, 等. 利用激光散斑成像技术观察尤瑞克林对脑梗死大鼠脑血流的影响[J]. 中华神经科杂志, 2010, 43(10): 732-736. DOI:10.3760/cma.j.issn.1006-7876.2010.10.016. Li CS, Min Z, Zhan YQ, et al. Use of laser speckle imaging to study effects of urinary kallidinogenase on cerebral blood flow following cerebral infarction in rats[J]. Chin J Neurol, 2010, 43(10): 732-736. DOI:10.3760/cma.j.issn.1006-7876.2010.10.016.
78. 徐恩, 缪学琼, 林清原, 等. 应用磁共振技术观察人尿激肽原酶对急性脑梗死患者脑血流灌注的影响[J]. 中国脑血管病杂志, 2009, 6(3): 124-128. Xu E, Miu XQ, Lin QY, et al. Effect of human urinary kallikrein on cerebral blood flow in patients with acute cerebral infarction by magnetic resonance imaging[J]. Chin J Cerebravasc Dis, 2009, 6(3): 124-128.
79. 谢丽华, 侯敬天, 侯玉立. 尤瑞克林治疗急性脑梗死Meta分析[J]. 中国卒中杂志, 2011, 6(4): 287-296. DOI:10.3969/j.issn.1673-5765.2011.04.008. Xie LH, Hou JT, Hou YL. Urinary kallid therapy for acute cerebral infarction: a meta analysis[J]. Chin J Stroke, 2011, 6(4): 287-296.DOI:10.3969/j.issn.1673-5765.2011.04.008.
80. 丁德云, 吕传真, 丁美萍, 等. 人尿激肽原酶治疗急性脑梗死多中心随机双盲安慰剂对照试验[J]. 中华神经科杂志, 2007, 40(5): 307-310. DOI:10.3760/j.issn: 1006-7876.2007.05.006. Ding DY, Lyu CZ, Ding MP, et al. A multicenter, randomized, double-blinded and placebo-controlled study of acute brain infarction treated by human urinary kallidinogenase[J]. Chin J Neurol, 2007, 40(5): 307-310. DOI:10.3760/j.issn: 1006-7876.2007.05.006.
81. Al-Khaled M, Matthis C, Eggers J. Statin treatment in patients with acute ischemic stroke[J]. Int J Stroke, 2014, 9(5): 597-601. DOI:10.1111/ijs.12256.
82. Hong KS, Lee JS. Statins in Acute Ischemic Stroke: A Systematic Review[J]. J Stroke, 2015, 17(3): 282-301. http://dx.doi.org/10.5853/jos.2015.17.3.282.
83. Yoshimura S, Uchida K, Daimon T, et al. Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke: ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient)[J]. Stroke, 2017, 48(11): 3057-3063. DOI:10.1161/STROKEAHA.117.017623.
84. Blanco M, Nombela F, Castellanos M, et al. Statin treatment withdrowal in ischemic stroke: a controlled radomized study[J]. Neurology, 2007, 69(9): 904-910.
85. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the Amercian College of Cardiology/Amercian Heart Association Task Force on the Practice Guideline[J]. Circulation, 2014, 129(25 Suppl 2): S1-45. DOI:10.1161/01.cir.0000437738.63853.7a.
86. Patel RAG, McMullen PW. Neuroprotection in the treatment of acute ischemic stroke[J]. Prog Cardiovasc Dis, 2017, 59(6): 542-548. DOI:10.1016/j.pcad.2017.04.005.
87. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, Placebo-Controlled, Double-Blind Study at multicenters[J]. Cerebrovasc Dis, 2003, 15(3): 222-229.
88. 顾学兰, 丁新生, 狄晴. 依达拉奉注射液治疗急性脑梗死的临床疗效评价[J]. 中国新药与临床杂志, 2005, 24(2): 113-116. Gu XL, Ding XS, Di Q. Clinical evaluation of Edaravone Injection in the treatment of acute cerebral infarction[J]. Chin J New Drugs Clin Remed, 2005, 24(2): 113-116.
89. 张明, 徐丽君, 邓丽影. 依达拉奉注射液治疗急性脑梗死疗效及安全性随机双盲多中心研究[J]. 中国新药与临床杂志, 2007, 26(2): 105-108. Zhang M, Xu LJ, Deng LY. Efficacy and safety of Edaravone Injection in the treatment of acute cerebral infarction: a randomized, double-blind, multicenter study[J]. Chin J New Drugs Clin Remed, 2007, 26(2): 105-108.
90. Wada T, Yasunaga H, Inokuchi R, et al. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.[J]J Neurol Sci, 2014, 345(1-2): 106-111. DOI:10.1016/j.jns.2014.07.018.
91. Nomani F, Kamal AK. Citicoline in the Treatment of Acute Ischaemic Stroke: An International, Randomized, Multicentre, Placebo-Controlled Study (ICTUS Trial) is the Use of Citicoline is Beneficial for Acute Ischaemic stroke?[J]J Pak Med Assoc, 2013, 63(11): 1445.
92. Secades JJ, Alvarez-Sabín J, Castillo J, et al. Citicoline for Acute Ischemic Stroke: A Systematic Review and Formal Meta-analysis of Randomized, Double-Blind, and Placebo-Controlled Trials.[J]J Stroke Cerebrovasc Dis, 2016, 25(8): 1984-1996. DOI:10.1016/j.jstrokecerebrovasdis.2016.04.010.
93. Ricci S, Celani MG, Cantisani TA, et al. Piracetam for acute ischaemic stroke[J/CD]. Cochrane Database Syst Rev, 2012, (9): CD000419. DOI:10.1002/14651858.CD000419.pub3.
94. Wu B, Liu M, Liu H, et al. Meta-analysis of traditional Chinese patent medicine for ischemic stroke[J]. Stroke, 2007, 38(6): 1973-1979.
95. Chen CL, Young SH, Gan HH, et al. Chinese medicine neuroaid efficacy on stroke recovery: a double-blind, placebo-controlled, randomized study[J]. Stroke, 2013, 44(8): 2093-2100.
96. Zhang SH, Liu M, Asplund K, et al. Acupuncture for acute stroke[J/CD]. Cochrane Database Syst Rev, 2005, (2): CD003317. DOI:10.1002/14651858.CD003317.pub2.
97. Zhang SH, Wu B, Liu M, et al. Acupuncture efficacy on ischemic stroke recovery: multicenter randomized controlled trial in China[J]. Stroke, 2015, 46(5): 1301-1306. DOI:10.1161/STROKEAHA.114.007659.
98. 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国重症脑血管病管理共识2015[J]. 中华神经科杂志, 2016, 49(3): 192-202. DOI:10.3760/cma.j.issn.1006-7876.2016.03.004. Chinese Society of Neurology, Chinese Stroke Society. Chinese consensus on the management of severe cerebrovascular disease 2015[J]. Chin J Neurol, 2016|, 49(3): 192-202. DOI:10.3760/cma.j.issn.1006-7876.2016.03.004.
99. Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials[J]. Lancet Neurol, 2007, 6(3): 215-222.
100. Jüttler E, Unterberg A, Woitzik J, et al; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral artery stroke[J]. N Engl J Med, 2014, 370(12): 1091-1100. DIO: 10.1056/NEJMoa1311367.
101. Wan YH, Nie C, Wang HL, et al. Therapeutic hypothermia (different depths, durations, and rewarming speeds) for acute ischemic stroke: a meta-analysis[J]. J Stroke Cerebrovasc Dis, 2014, 23(10): 2736-2747. DOI:10.1016/j.jstrokecerebrovasdis.2014.06.017.
102. Su Y, Fan L, Zhang Y, et al. Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction[J]. Stroke, 2016, 47(2): 457-463. DOI:10.1161/STROKEAHA.115.009789.
103. Lindley RI, Wardlaw JM, Sandercock PA, et al. Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction[J]. J Stroke Cerebrovasc Dis, 2004, 13(6): 235-246.
104. 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南[J]. 中华神经科杂志, 2015, 48(6): 435-444. DOI:10.3760/cma.j.issn.1006-7876.2015.06.002.Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for diagnosis and treatment of cerebral hemorrhage[J]. Chin J Neurol, 2015, 48(6): 435-444. DOI:10.3760/cma.j.issn.1006-7876.2015.06.002.
105. André C, de Freitas GR, Fukujima MM. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles[J]. Eur J Neurol, 2007, 14(1): 21-32.
106. Kearon C, AkI EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report[J]. Chest, 2016, 149(2): 315-352. DOI:10.1016/j.chest.2015.11.026.
107. 中华医学会肠外肠内营养学分会神经疾病营养支持学组. 神经系统疾病肠内营养支持操作规范共识(2011版)[J]. 中华神经科杂志, 2011, 44(11): 787-791. DOI:10.3760/cma.j.issn.1006-7876.2011.11.018.Group of Nutritional Support of Nerve Disease, Chinese Society of Enteral Nutrition. Standardized consensus on enteral nutrition support for nervous system diseases[J]. Chin J Neurol, 2011, 44(11): 787-791. DOI:10.3760/cma.j.issn.1006-7876.2011.11.018.
108. 中华医学会神经病学分会, 中华医学会神经病学分会神经康复学组, 中华医学会神经病学分会脑血管病学组. 中国脑卒中早期康复治疗指南[J]. 中华神经科杂志, 2017, 50(6): 405-412.Chinese Society of Neurology, Chinese Neurorehabilitation Society, Chinese Stroke Society. Chinese guidelines for early rehabilitation of stroke [J]. Chin J Neurol, 2017, 50(6): 405-412.
109. 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J]. 中华神经科杂志, 2015, 48(4): 258-273. DOI:10.3760/cma.j.issn.1006-7876.2015.04.003. Chinese Society of Neurology, Chinese Stroke Society. Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack 2014[J]. Chin J Neurol, 2015,| 48(4): 258-273. DOI:10.3760/cma.j.issn.1006-7876.2015.04.003.